Literature DB >> 16574405

SF-1 overexpression in childhood adrenocortical tumours.

Mara A D Pianovski1, Luciane R Cavalli, Bonald C Figueiredo, Savana C L Santos, Mabrouka Doghman, Raul C Ribeiro, Antonio G Oliveira, Edson Michalkiewicz, Giovanna A Rodrigues, Gerard Zambetti, Bassem R Haddad, Enzo Lalli.   

Abstract

The steroidogenic factor 1 (SF-1) gene encodes a transcription factor playing a pivotal role in the regulation of adrenogenital development. We have recently shown that SF-1 is amplified in childhood adrenocortical tumours (ACT). This study was aimed to assess if an increase in SF-1 gene copy number was associated with increased protein levels and to study the correlation between SF-1 expression and ACT clinical parameters. An increased SF-1 copy number was detected in eight of the 10 ACT cases studied. Conversely, the SF-1 protein was found to be overexpressed in all cases, compared to normal age-matched adrenal glands. No significant correlation was found between SF-1 protein levels and its gene copy number. Furthermore, no significant correlation existed with histological grade or with the clinical manifestation or evolution of disease. This data show that SF-1 overexpression is widespread in childhood ACT and is likely to play a role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574405     DOI: 10.1016/j.ejca.2006.01.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

Review 1.  Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Authors:  Derek P Simon; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2012-01-13       Impact factor: 4.102

Review 2.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

3.  Emerging therapy for adrenocortical carcinoma.

Authors:  Rachel D Aufforth; Naris Nilubol
Journal:  Int J Endocr Oncol       Date:  2014

Review 4.  Regulation of the adrenocortical stem cell niche: implications for disease.

Authors:  Elisabeth M Walczak; Gary D Hammer
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

5.  SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1.

Authors:  Megumi Hatano; Toshiro Migita; Tomokazu Ohishi; Yuichi Shima; Yoshihiro Ogawa; Ken-Ichirou Morohashi; Yukihiro Hasegawa; Futoshi Shibasaki
Journal:  Endocrine       Date:  2016-07-25       Impact factor: 3.633

6.  High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.

Authors:  Roberto Rosati; Flavia Cerrato; Mabrouka Doghman; Mara A D Pianovski; Guilherme A Parise; Gislaine Custódio; Gerard P Zambetti; Raul C Ribeiro; Andrea Riccio; Bonald C Figueiredo; Enzo Lalli
Journal:  Cancer Genet Cytogenet       Date:  2008-10

7.  POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells.

Authors:  Monica Malheiros França; Bruno Ferraz-de-Souza; Mariza Gerdulo Santos; Antonio Marcondes Lerario; Maria Candida Barisson Villares Fragoso; Ana Claudia Latronico; Rork D Kuick; Gary D Hammer; Claudimara F P Lotfi
Journal:  Mol Cell Endocrinol       Date:  2013-01-09       Impact factor: 4.102

Review 8.  Phospholipid--driven gene regulation.

Authors:  Paul M Musille; Jeffrey A Kohn; Eric A Ortlund
Journal:  FEBS Lett       Date:  2013-01-16       Impact factor: 4.124

Review 9.  In search of adrenocortical stem and progenitor cells.

Authors:  Alex C Kim; Ferdous M Barlaskar; Joanne H Heaton; Tobias Else; Victoria R Kelly; Kenneth T Krill; Joshua O Scheys; Derek P Simon; Alessia Trovato; Wei-Hsiung Yang; Gary D Hammer
Journal:  Endocr Rev       Date:  2009-04-29       Impact factor: 19.871

10.  Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.

Authors:  Helka Parviainen; Anja Schrade; Sanne Kiiveri; Renata Prunskaite-Hyyryläinen; Caj Haglund; Seppo Vainio; David B Wilson; Johanna Arola; Markku Heikinheimo
Journal:  Pathol Res Pract       Date:  2013-06-21       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.